DongKook Pharmaceutical Co. Ltd Capital Reinvestment Ratio

Latest as of June 2026: 0.63x

DongKook Pharmaceutical Co. Ltd capital reinvestment ratio. DongKook Pharmaceutical Co. Ltd (086450) has a Capital Reinvestment Ratio of 0.63x as of June 2026, meaning it reinvests 1% of its operating cash flow (₩32.26 Billion) in capital expenditures (₩20.17 Billion). See DongKook Pharmaceutical Co. Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.63x
Capex / Operating Cash Flow

Operating Cash Flow

₩32.26 Billion
KRW

Capital Expenditures

₩20.17 Billion
KRW

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of DongKook Pharmaceutical Co. Ltd (2013–2025)

Capital reinvestment ratio of DongKook Pharmaceutical Co. Ltd from 2013 to 2025. This chart tracks DongKook Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 13 annual periods. See DongKook Pharmaceutical Co. Ltd (086450) flexibility index to measure the company's free cash flow as a share of total liabilities.

DongKook Pharmaceutical Co. Ltd Capital Reinvestment Ratio by Year (2013–2025)

DongKook Pharmaceutical Co. Ltd capital reinvestment ratio by year from 2013 to 2025. For the full cash flow conversion analysis, see cash flow conversion of DongKook Pharmaceutical Co. Ltd.

Year Reinvestment Ratio Operating CF (KRW) Capital Expenditures YoY Change
2025 0.67x ₩68.76 Billion ₩46.00 Billion ▲ +65.2%
2024 0.40x ₩76.09 Billion ₩30.80 Billion ▼ -57.0%
2023 0.94x ₩41.79 Billion ₩39.35 Billion ▼ -24.8%
2022 1.25x ₩40.91 Billion ₩51.23 Billion ▲ +9.6%
2021 1.14x ₩44.65 Billion ₩51.01 Billion ▲ +70.5%
2020 0.67x ₩59.11 Billion ₩39.61 Billion ▲ +85.3%
2019 0.36x ₩69.48 Billion ₩25.13 Billion ▼ -84.1%
2018 2.27x ₩33.21 Billion ₩75.46 Billion ▲ +457.8%
2017 0.41x ₩28.66 Billion ₩11.67 Billion ▲ +66.9%
2016 0.24x ₩39.41 Billion ₩9.62 Billion ▼ -30.9%
2015 0.35x ₩27.14 Billion ₩9.60 Billion ▼ -40.8%
2014 0.60x ₩22.74 Billion ₩13.59 Billion ▲ +197.2%
2013 0.20x ₩19.86 Billion ₩3.99 Billion —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow